Dedicated to Pioneering Innovation
Dr. Kashif Khan is the CSO of Sonaro and a CIHR Vanier Scholar,
with a focus on applying AI and medical imaging to streamline
cardiovascular disease screening, particularly in carotid
atherosclerosis.
Dr. Khan completed his PhD in 2022 and his MD in 2024, both from
McGill University, and is currently a first-year internal medicine
resident. He has published 22 peer-reviewed academic papers on
cardiovascular research, including the biological mechanisms of
atherosclerosis and stem cell use for cardiac regeneration.
LinkedIn Profile
Karina is a distinguished scientist and entrepreneur with over a
decade of experience in cardiovascular research. She earned her
PhD in Experimental Medicine and completed a Postdoctoral
Fellowship at McGill University, where she received numerous
awards for her research, before transitioning into
entrepreneurship.
Beyond her role at Sonaro, Karina serves as the Director of
Technology at the World Youth Heart Federation, where she
champions the involvement of youth in advancing cardiovascular
health technology. Karina is passionate about leveraging her
scientific background and entrepreneurial skills to make a lasting
impact on global health. Her leadership at Sonaro reflects her
commitment to improving patient outcomes through innovative
technology.
LinkedIn Profile
Thierry Beiko is an experienced AI developer and biomedical
engineer with five years of expertise at the intersection of
software development, artificial intelligence, and medical
technology. Thierry specializes in medical imaging, deep learning,
and computer vision, having worked on groundbreaking projects such
as medical image noise reduction and artery segmentation. He has a
proven track record of delivering innovative AI solutions in
highly regulated industries.
Now a full-time AI Developer at Sonaro, Thierry continues to drive
healthcare technology forward by developing deep learning models
and robust data infrastructure, reflecting his passion for
enhancing medical outcomes and improving patient care.
LinkedIn Profile
Dr. Jose L. Ramirez-GarciaLuna is a highly accomplished medical
professional with a diverse educational background and extensive
experience in clinical practice, academia, and the medical
technology industry. He earned his MD and an MSc in Epidemiology
and Biostatistics from Universidad Autonoma de San Luis Potosi in
Mexico and is certified as an emergency and critical care
physician.
Driven by his passion for science, Dr. Ramirez-GarciaLuna earned a
PhD in Experimental Surgery and a Certificate in Surgical
Innovation at McGill University in Canada in 2020. His research
focuses on biomaterials for wound healing, translational research,
the immunology of wound healing, innovation, and e-Health. He is
considered a pioneer in the clinical translation of hyperspectral
imaging, machine learning, and artificial intelligence to address
surgical challenges, with a particular emphasis on wound healing
and infection detection. His dedication and expertise have
resulted in the publication of over 60 peer-reviewed articles.
LinkedIn Profile
Dr. Sabir Taj is an interventional radiologist with over 10 years of experience in image-guided procedures. He is certified in both interventional and diagnostic radiology by the American Board of Radiology. He is currently Vice-Chair of the Department of Radiology at Johns Hopkins Howard County Medical Center. Dr. Taj serves on the board of Sonaro AI as the Lead Medical Imaging Advisor.
LinkedIn Profile
Alex Benjamin graduated from the Massachusetts Institute of
Technology with a PhD in Computational Sciences. His thesis work
focused on the use of ultrasound imaging, computer vision and
medical robotics to reconstruct 3D organ property maps for disease
monitoring. He has authored numerous publications and technology
disclosures.
Having co-founded 2 medical device startups in the past, he is
well versed with the space and has a proven track record of
experience in translating deep tech ideas into commercial
products.
LinkedIn Profile
Yehor is an accomplished Full-Stack Developer with a strong
passion for creating impactful digital solutions. With extensive
experience building startups from the ground up as a Chief
Technology Officer, he excels at navigating the challenges of
early-stage development and implementation. His role as a Subject
Matter Expert at IBM involved leading a technical support team,
where he focused on quality assurance and conducted comprehensive
training sessions to elevate team performance.
At Ring, Yehor successfully pitched and led a support automation
project, streamlining processes and enhancing customer
satisfaction through innovative solutions. His technical expertise
encompasses both system design and UI/UX design, along with
frontend and backend development and cloud technologies, making
him adept at delivering comprehensive solutions. With a commitment
to modern technologies and user-centric design, Yehor is dedicated
to driving innovation in healthcare and beyond, contributing to
Sonaro's mission of revolutionizing cardiovascular care.
LinkedIn Profile
Our Journey and Vision for the Future
Sonaro Incorporated officially established with a mission to revolutionize cardiovascular care through advanced diagnostic tools like Vaso3D™.
Sonaro's proprietary technology, Vaso3D™, is protected under an international patent application, paving the way for secure global expansion and commercialization.
Completion of initial data collection for Vaso3D™, providing a robust dataset to validate and refine the AI algorithms used in detecting vascular diseases.
The clinical pilot study commenced, successfully assessing the effectiveness and accuracy of Vaso3D™ in a real-world medical environment. The study gathered valuable feedback that was used to further improve the product. Preliminary data demonstrated a 90% reduction in ultrasound scan time with Vaso3D™.
Successful FDA pre-submission meeting confirms Vaso3D™ falls under the Class II 510(k) pathway, providing regulatory clarity for the commercialization roadmap.
Comprehensive clinical validation studies to further demonstrate Vaso3D™'s efficacy, safety, and clinical benefits for regulatory submission.
Vaso3D™ FDA submission, a critical step toward bringing this innovative diagnostic tool to market. The submission includes comprehensive data from clinical trials and pilot studies.
The US Product Launch is a major milestone for Vaso3D™, introducing advanced vascular diagnostics nationwide. After rigorous testing and approvals, Vaso3D™ is set to transform stroke prevention with early detection and intervention for vascular diseases.
